Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation of a Points Score System Predicting 30-day Survival for Patients With Metastatic Cancer Receiving Palliative Radiation Therapy

NCT05100342 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05100342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation of a Points Score System Predicting 30-day Survival for Patients With Metastatic Cancer Receiving Palliative Radiation Therapy
Lead sponsor
Indiana University
Phase
Observational
Overall status
Recruiting
Start date
September 12, 2022
Completion date
July 31, 2028
Enrollment
214 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer